Eleven Therapeutics vs Immunai
Eleven Therapeutics vs Immunai, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Eleven Therapeutics is on 56/100 and Immunai on 69/100.
Where each one leads
Eleven Therapeutics
- agent readiness: 40/100 against 32/100
- headcount growth: +17.6% against +13.0%
Immunai
- our overall score: 69/100 against 56/100
- domain rating: 46/100 against 13/100
- headcount: 179 against 28
- funding raised: $295M against $22.0M
- LinkedIn following: 26,832 against 5,528
At a glance
| Measure | Eleven Therapeutics | Immunai |
|---|---|---|
| What it is | Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases. | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. |
| Category | Healthcare, Life Sciences, Therapeutics, Biotech | Healthcare, Immunology, Data, Analytics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2017 | 2019 |
| Headquarters | London, United Kingdom | New York, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Eleven Therapeutics | Immunai |
|---|---|---|
| Employees | 28 | 179 |
| Headcount growthLast 12 months | +17.6% | +13.0% |
| Open roles | 4 | Not published |
| Total funding | $22.0M | $295M |
| Latest round | Seed | Series B |
| Valuation | Not published | $1.0B |
| LinkedIn followers | 5,528 | 26,832 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Eleven Therapeutics | Immunai |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 69/100 |
| Traction | 51/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 30/100 | 39/100 |
| Quality | 58/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Eleven Therapeutics | Immunai |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
Eleven Therapeutics vs Immunai: common questions
Which is better, Eleven Therapeutics or Immunai?
On our 0-100 score Immunai rates higher (69/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Eleven Therapeutics and Immunai compare on the numbers?
Eleven Therapeutics leads on agent readiness (40/100 against 32/100), headcount growth (+17.6% against +13.0%). Immunai leads on our overall score (69/100 against 56/100), domain rating (46/100 against 13/100), headcount (179 against 28), funding raised ($295M against $22.0M), LinkedIn following (26,832 against 5,528).
Read the full Eleven Therapeutics review and pricing or the Immunai review and pricing. You can also browse other Eleven Therapeutics alternatives we track.